Regeneron Pharmaceuticals (REGN) Net Cash Flow Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 89.97% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -13.44% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 33.37% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -29.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.82% |
| Dec 31, 2025 | 53.05% |
| Sep 30, 2025 | 72.98% |
| Jun 30, 2025 | -187.72% |
| Mar 31, 2025 | 9.38% |
| Dec 31, 2024 | 42.18% |
| Sep 30, 2024 | -60.66% |
| Jun 30, 2024 | -45.40% |
| Mar 31, 2024 | 44.77% |
| Dec 31, 2023 | -2.38% |
| Sep 30, 2023 | 35.79% |
| Jun 30, 2023 | -109.24% |
| Mar 31, 2023 | 11.09% |
| Dec 31, 2022 | -54.03% |
| Sep 30, 2022 | -34.31% |
| Jun 30, 2022 | 27.54% |
| Mar 31, 2022 | 24.18% |
| Dec 31, 2021 | -50.95% |
| Sep 30, 2021 | 100.05% |
| Jun 30, 2021 | 102.01% |